Clara Amiama Roig

Assessment of metabolic biomarkers associated with hepatic steatosis in Crohn’s disease

Cristina Suárez Ferrer, Marta Abadía, María Gema Crespo Sanchez, Jose Luis Rueda García et autres

Factors Influencing Clinical and Radiological Response in Perianal Disease: Results from a Real-World Cohort Treated with Anti-TNF Therapy

Clara Amiama Roig, Cristina Suárez-Ferrer, José Luis Rueda García, Laura García Ramírez et autres

Background: Perianal Crohn’s disease (PD) remains a major therapeutic challenge, with heterogeneous responses to anti-TNF therapy and limited real-world data on predictors of long-term outcomes. This study aimed to evaluate clinical and radiological response to anti-TNF therapy initiated exclusively for PD and …

es (code pays fourni par la source)

72 - EVALUACIÓN DE LA ESTEATOSIS HEPÁTICA METABÓLICA MEDIANTE ATI EN PACIENTES CON ENFERMEDAD DE CROHN Y SU RELACIÓN CON LA ACTIVIDAD DE LA EII

Cristina Suárez Ferrer, Marta Abadía Barnó, Gema Crespo Sanchez, Jose Luis Rueda García et autres

Factors Influencing Clinical and Radiological Response in Perianal Disease: Results from a Real-World Cohort Treated with Anti-TNF Therapy

Clara Amiama Roig, José López Miranday Antonio Camargo García, Cristina Suárez Ferrer, Laura García Ramírez et autres

Background: Perianal Crohn's disease (PD) remains a major therapeutic challenge, with heterogeneous responses to anti-TNF therapy and limited real-world data on predictors of long-term outcomes. This study aimed to evaluate clinical and radiological response to anti-TNF therapy initiated exclusively for PD and …

es (code pays fourni par la source)

Determinants of HBsAg Loss After Nucleos(t)ide Discontinuation in a Prospective Cohort of HBeAg ‐Negative Caucasian Patients

Anna Pocurull, Teresa Broquetas, Elena Hoyas, Manuel Rodríguez et autres

INTRODUCTION: Nucleos(t)ide analogues (NAs) discontinuation in HBeAg-negative chronic hepatitis B (CHB) aims at increasing functional cure rates. However, clinical outcomes and predictive factors for HBsAg loss or re-treatment are affected by the heterogeneity of studies. We aimed to analyse baseline factors associated …

es (code pays fourni par la source)

Association of early therapeutic drug monitoring of adalimumab with biologic remission and drug survival in Crohn’s Disease

J L Rueda García, Cristina Suárez Ferrer, Clara Amiama Roig, Laura García Ramírez et autres

Background: Therapeutic drug monitoring of adalimumab (ADA) is still controversial. Objectives: To study the association between ADA trough levels in the early stages of treatment with biological remission (BR) and drug survival in Crohn's disease (CD). Design: Retrospective cohort study. Methods: Patients …

es (code pays fourni par la source)

Comparison of endoscopic ultrasound (EUS)-guided fine needle aspiration with and without rapid onsite evaluation of cytopathology (ROSE) in solid lesions

Carmen Amor Costa, Gloria Ruiz Fernández, J L Rueda García, Consuelo Froilán Torres et autres

Aims Endoscopic ultrasound (EUS) and fine-needle aspiration (FNA) are the gold standard techniques for the diagnosis of solid pancreatic and peripancreatic lesions [ 1 ]. The reported diagnostic yield of EUS-FNA is approximately 78% [ 2 ], and the benefit of rapid …

es (code pays fourni par la source)

Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease

Carmen Amor Costa, Cristina Suárez Ferrer, Laura García Ramírez, Eduardo Martín-Arranz et autres

es (code pays fourni par la source)

P0288 Translation and validation of the IBD-Disk as a tool for assessing the degree of disability in a cohort of Spanish-speaking patients with inflammatory bowel disease. TRAVIDI study.

Carlos González‐Muñoza, Antonio Giordano, Cristina Gely, Jaylo Abalos et autres

Abstract Background Inflammatory bowel diseases (IBD), such as Crohn’s disease (CD) and ulcerative colitis (UC), impact patients’ quality of life, affecting them during both active periods and remission. Recently, tools have been designed to align therapeutic goals between patients and healthcare professionals, …

P0540 Assessment of Metabolic-Associated Liver Disease in Patients with Crohn’s Disease in Long-Term Remission

Clara Amiama Roig, Suárez Ferrer Cristina, Gil Laura, Rita Luís et autres

Abstract Background Previous studies have shown that patients with Crohn’s disease(CD) have an increased risk of metabolic liver disease(MASLD) even in the absence of cardiovascular risk factors. This increased prevalence is attributed to the inflammatory bowel activity itself. However, there is less …

es (code pays fourni par la source)

Prospective validation of the EASL-EASD algorithm for risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes

Clara Amiama Roig, Miriam Romero, Noemí González, Pilar Castillo Grau et autres

BACKGROUND AND AIM: individuals with type 2 diabetes are at increased risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD). The European Association for the Study of Diabetes (EASD) recently proposed a two-step algorithm for risk stratification and referral, developed in collaboration …

es (code pays fourni par la source)

Valoración de la transición de vedolizumab intravenoso a subcutáneo en pacientes con enfermedad inflamatoria intestinal

Carmen Amor Costa, Cristina Suárez Ferrer, Laura García Ramírez, Eduardo Martín-Arranz et autres

es (code pays fourni par la source)